411 related articles for article (PubMed ID: 22582044)
1. Aldose reductase, oxidative stress, and diabetic mellitus.
Tang WH; Martin KA; Hwa J
Front Pharmacol; 2012; 3():87. PubMed ID: 22582044
[TBL] [Abstract][Full Text] [Related]
2. The role of aldose reductase in polyol pathway: An emerging pharmacological target in diabetic complications and associated morbidities.
Gupta JK
Curr Pharm Biotechnol; 2023 Aug; ():. PubMed ID: 37649296
[TBL] [Abstract][Full Text] [Related]
3. Recent studies of aldose reductase enzyme inhibition for diabetic complications.
Suzen S; Buyukbingol E
Curr Med Chem; 2003 Aug; 10(15):1329-52. PubMed ID: 12871133
[TBL] [Abstract][Full Text] [Related]
4. Aldose reductase inhibition: emerging drug target for the treatment of cardiovascular complications.
Reddy AB; Ramana KV
Recent Pat Cardiovasc Drug Discov; 2010 Jan; 5(1):25-32. PubMed ID: 19886861
[TBL] [Abstract][Full Text] [Related]
5. Aldose Reductase: An Emerging Target for Development of Interventions for Diabetic Cardiovascular Complications.
Jannapureddy S; Sharma M; Yepuri G; Schmidt AM; Ramasamy R
Front Endocrinol (Lausanne); 2021; 12():636267. PubMed ID: 33776930
[TBL] [Abstract][Full Text] [Related]
6. Physiological and Pathological Roles of Aldose Reductase.
Singh M; Kapoor A; Bhatnagar A
Metabolites; 2021 Sep; 11(10):. PubMed ID: 34677370
[TBL] [Abstract][Full Text] [Related]
7. Aldose Reductase and the Polyol Pathway in Schwann Cells: Old and New Problems.
Niimi N; Yako H; Takaku S; Chung SK; Sango K
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494154
[TBL] [Abstract][Full Text] [Related]
8. [Aldose reductase in the polyol pathway: a potential target for the therapeutic intervention of diabetic complications].
Nishimura-Yabe C
Nihon Yakurigaku Zasshi; 1998 Mar; 111(3):137-45. PubMed ID: 9583077
[TBL] [Abstract][Full Text] [Related]
9. Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-diabetic Diseases.
Grewal AS; Bhardwaj S; Pandita D; Lather V; Sekhon BS
Mini Rev Med Chem; 2016; 16(2):120-62. PubMed ID: 26349493
[TBL] [Abstract][Full Text] [Related]
10. Aldose Reductase as a Key Target in the Prevention and Treatment of Diabetic Retinopathy: A Comprehensive Review.
Dănilă AI; Ghenciu LA; Stoicescu ER; Bolintineanu SL; Iacob R; Săndesc MA; Faur AC
Biomedicines; 2024 Mar; 12(4):. PubMed ID: 38672103
[TBL] [Abstract][Full Text] [Related]
11. Sorbinil, an Aldose Reductase Inhibitor, in Fighting Against Diabetic Complications.
Huang Q; Liu Q; Ouyang D
Med Chem; 2019; 15(1):3-7. PubMed ID: 29792152
[TBL] [Abstract][Full Text] [Related]
12. Aldose reductase inhibition protects diabetic and nondiabetic rat hearts from ischemic injury.
Ramasamy R; Oates PJ; Schaefer S
Diabetes; 1997 Feb; 46(2):292-300. PubMed ID: 9000707
[TBL] [Abstract][Full Text] [Related]
13. Aldose reductase-deficient mice are protected from delayed motor nerve conduction velocity, increased c-Jun NH2-terminal kinase activation, depletion of reduced glutathione, increased superoxide accumulation, and DNA damage.
Ho EC; Lam KS; Chen YS; Yip JC; Arvindakshan M; Yamagishi S; Yagihashi S; Oates PJ; Ellery CA; Chung SS; Chung SK
Diabetes; 2006 Jul; 55(7):1946-53. PubMed ID: 16804062
[TBL] [Abstract][Full Text] [Related]
14. Aldose reductase and cardiovascular diseases, creating human-like diabetic complications in an experimental model.
Ramasamy R; Goldberg IJ
Circ Res; 2010 May; 106(9):1449-58. PubMed ID: 20466987
[TBL] [Abstract][Full Text] [Related]
15. Redox imbalance stress in diabetes mellitus: Role of the polyol pathway.
Yan LJ
Animal Model Exp Med; 2018 Mar; 1(1):7-13. PubMed ID: 29863179
[TBL] [Abstract][Full Text] [Related]
16. Development of Aldose Reductase Inhibitors for the Treatment of Inflammatory Disorders and Cancer: Current Drug Design Strategies and Future Directions.
Sonowal H; Ramana KV
Curr Med Chem; 2021; 28(19):3683-3712. PubMed ID: 33109031
[TBL] [Abstract][Full Text] [Related]
17. Aldose Reductase as a Drug Target for Treatment of Diabetic Nephropathy: Promises and Challenges.
ElGamal H; Munusamy S
Protein Pept Lett; 2017; 24(1):71-77. PubMed ID: 27894247
[TBL] [Abstract][Full Text] [Related]
18. Contribution of polyol pathway to diabetes-induced oxidative stress.
Chung SS; Ho EC; Lam KS; Chung SK
J Am Soc Nephrol; 2003 Aug; 14(8 Suppl 3):S233-6. PubMed ID: 12874437
[TBL] [Abstract][Full Text] [Related]
19. Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options.
Srivastava SK; Ramana KV; Bhatnagar A
Endocr Rev; 2005 May; 26(3):380-92. PubMed ID: 15814847
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of flavonoids and their effects on aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues.
Lim SS; Jung SH; Ji J; Shin KH; Keum SR
J Pharm Pharmacol; 2001 May; 53(5):653-68. PubMed ID: 11370705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
